Publications by authors named "Hancai Dan"

Claim this Profile
E
Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma.
Xinyan Geng, Shirin Azarbarzin, Zejia Yang, Rena G Lapidus, Xiaoxuan Fan, Hancai Dan

Oncol Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.
Jipei Liao, Zejia Yang, Shirin Azarbarzin, Kevin J Cullen, Hancai Dan

Head Neck· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer.
Liwei Lang, Fanghui Chen, Yamin Li, Chloe Shay, Fan Yang, Hancai Dan

Cancer Res Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.
Samusi Adediran, Linbo Wang, Mohammad Afnan Khan, Wei Guang, Xiaoxuan Fan, Hancai Dan

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
Zejia Yang, Jipei Liao, Lisa Schumaker, Brandon Carter-Cooper, Rena G Lapidus, Hancai Dan

Oral Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma.
Zejia Yang, Jipei Liao, Rena G Lapidus, Xiaoxuan Fan, Ranee Mehra, Hancai Dan

Cancer Chemother Pharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma.
Zejia Yang, Jipei Liao, Kevin J Cullen, Hancai Dan

Cell Death Discov· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
Jipei Liao, Zejia Yang, Brandon Carter-Cooper, Elizabeth T Chang, Eun Yong Choi, Hancai Dan

Clin Exp Metastasis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent inhibition of ErbB family and MEK/ERK kinases to suppress non-small cell lung cancer proliferation.
Xiaofeng Lin, Jipei Liao, Xinyan Geng, Hancai Dan, Long Chen

Am J Transl Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
Nancy Palechor-Ceron, Ewa Krawczyk, Aleksandra Dakic, Vera Simic, Hang Yuan, Hancai Dan

Cells· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cisplatin-resistant head and neck squamous cell carcinoma by combination of Afatinib with PD0325901, a MEK inhibitor.
Xiaofeng Lin, Jipei Liao, Zejia Yang, Xiaoxuan Fan, Kevin J Cullen, Hancai Dan

Am J Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
Zejia Yang, Jipei Liao, Brandon A Carter-Cooper, Rena G Lapidus, Kevin J Cullen, Hancai Dan

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Zhipeng Li, Jipei Liao, Zejia Yang, Eun Yong Choi, Rena G Lapidus, Hancai Dan

Br J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Rui Cao, Zhe Meng, Tongzu Liu, Gang Wang, Guofeng Qian, Hancai Dan

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.
Kazuhiro Tanaka, Ivan Babic, David Nathanson, David Akhavan, Deliang Guo, Julie Dang, Hancai Dan, Brendan D Manning

Cancer Discov· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis